Docon Technologies Updates Encumbrance Disclosure for Thyrocare Technologies Shares Following Partial NCD Redemption
Docon Technologies Private Limited updated its SEBI SAST disclosure following API Holdings Limited's partial redemption of INR 1,200 million Series 1 NCDs on March 30, 2026, through face value reduction from INR 10,00,000 to INR 9,00,000 per debenture. The number of encumbered Thyrocare Technologies shares remains unchanged at 9,69,69,696 shares (60.93% of share capital), with encumbrance continuing in favor of Catalyst Trusteeship Limited as Debenture Trustee.

*this image is generated using AI for illustrative purposes only.
Docon Technologies Private Limited has filed an updated disclosure under Regulation 31 of SEBI (SAST) Regulations, 2011, regarding the encumbrance on shares of Thyrocare Technologies Limited. The update follows a significant corporate action by API Holdings Limited involving the partial redemption of its Series 1 Non-Convertible Debentures.
Partial Redemption Details
API Holdings Limited executed a partial redemption of its Series 1 Non-Convertible Debentures aggregating to INR 1,200 million on March 30, 2026. The redemption was structured through a reduction in face value per debenture from INR 10,00,000 to INR 9,00,000.
| Parameter: | Details |
|---|---|
| Redemption Amount: | INR 1,200 million |
| Redemption Date: | March 30, 2026 |
| Face Value Reduction: | INR 10,00,000 to INR 9,00,000 per debenture |
| Method: | Reduction of face value per debenture |
Share Encumbrance Status
Despite the partial redemption, there has been no change in the number of encumbered shares of Thyrocare Technologies Limited held by Docon Technologies Private Limited. The encumbrance details remain as follows:
| Metric: | Current Position |
|---|---|
| Encumbered Shares: | 9,69,69,696 shares |
| Percentage of Total Share Capital: | 60.93% |
| Encumbrance Holder: | Catalyst Trusteeship Limited |
| Capacity: | Debenture Trustee for NCDs issued by API Holdings Limited |
Updated Debenture Structure
Following the partial redemption, the Series 1 Debentures now comprise 12,000 unlisted, unrated, secured, redeemable, non-convertible debentures with a reduced face value of INR 9,00,000 per debenture, aggregating to a nominal value of INR 10,800 million.
Major Debenture Holders
The disclosure reveals the current composition of debenture holders following the redemption:
| Debenture Holder: | Amount (INR Million) |
|---|---|
| 360 One Prime Limited: | 2,497.50 |
| Micro Labs Limited: | 2,266.20 |
| Tata Capital Limited: | 1,125.00 |
| 360 One Commercial Yield Fund: | 810.00 |
| 360 One Real Assets Advantage Fund: | 657.00 |
| J Kumar Infraprojects Limited: | 540.00 |
| Bennett Coleman And Company Limited: | 450.00 |
Regulatory Compliance
The updated disclosure was made to both the National Stock Exchange of India Limited and BSE Limited, along with Thyrocare Technologies Limited, in compliance with Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This follows previous disclosures made on September 24, 2025, November 11, 2025, and December 05, 2025.
The encumbrance on Docon's shares was created pursuant to a corporate guarantee extended by Docon Technologies Private Limited to secure the obligations of API Holdings Limited, its holding company, in respect of facilities availed through the issuance of the non-convertible debentures.
Historical Stock Returns for Thyrocare Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.56% | -3.03% | -8.04% | -6.43% | +50.48% | +24.23% |
Will API Holdings pursue further partial redemptions of the remaining INR 10,800 million debentures given the successful completion of this INR 1,200 million redemption?
How might the continued encumbrance of 60.93% of Thyrocare's shares impact potential strategic decisions or M&A activities for the company?
What factors could lead to the release of the share encumbrance held by Catalyst Trusteeship Limited in the near term?


































